Comparing two ways to give efgartigimod in healthy volunteers
This study compares two methods of giving the drug efgartigimod under the skin in healthy adults. It helps ensure both methods work the same way, which may make treatment easier for patients in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You weigh between 110 and 220 pounds (50 to 100 kg).
- Your body mass index (BMI) is between 18 and 30.
- You have not taken any prescription or over-the-counter medications in the last 2 weeks (except birth control or hormone therapy for women).
- You have not received efgartigimod in a previous clinical study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called efgartigimod for people with myasthenia gravis who need regular IVIG treatments. The goal is to see if efgartigimod can help reduce the need for IVIG.
This trial tests a new drug called ARGX-124 in healthy people to see if it is safe. It is a first step before testing it in patients with certain conditions.
This study tests the long-term safety and effectiveness of a subcutaneous (under-the-skin) version of efgartigimod for adults with active idiopathic inflammatory myopathy. It is for people who have already completed an earlier study of this medicine.
This study looks at how well efgartigimod works in everyday use for people with chronic inflammatory demyelinating polyneuropathy (CIDP). It aims to understand the real-world benefits of this treatment.
This study tests an investigational drug called efgartigimod for children and teens with generalized myasthenia gravis. It may help those who haven't responded well enough to standard treatments.
This study tests a new treatment called efgartigimod for people who have been recently diagnosed with generalized myasthenia gravis (gMG). It aims to see if this medicine can help manage symptoms like muscle weakness.
Hear when a new Healthy Volunteer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.